Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900026605Phase 4Not yet recruiting
Phase 4, open-label trial of lidocaine and propofol in pain (3 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoints: Total induction dose of propofol, Postoperative pain and 5 more. Planned start Oct 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900026605.